A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies
1 other identifier
observational
1,027
1 country
1
Brief Summary
This is a randomized, decentralized, non-interventional clinical study. The primary objective of this study is to develop execution and efficiency metrics from completion of this study to inform on the potential design for future projects. The secondary objective of this study is to assess the main study endpoints across balanced attributes of study sub-populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 13, 2025
CompletedFirst Submitted
Initial submission to the registry
July 21, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedDecember 19, 2025
December 1, 2025
5 months
July 21, 2025
December 12, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Interaction efficiency (contacted vs. enrolled)
The number and percentage of subjects who interacted with the digital study activities vs number and percentage of subjects who completed the study.
4 weeks post Last Subject's remote visit
Percent completion of subject self-taken images
The number and percentage of subjects who successfully completed the self-taken images.
4 weeks post Last Subject's remote visit
Percent completion of subjects participating in bio-sampling subset
The number and percentage of subjects who successfully completed the bio-sampling procedures.
4 weeks post Last Subject's remote visit
Secondary Outcomes (2)
Questionnaire results compared across skin tone
4 weeks post Last Subject's remote visit
Questionnaire results compared across age groups
4 weeks post Last Subject's remote visit
Study Arms (2)
Non-Skin Microbiome Subset
18- to 65-year-old female subjects.
Skin Microbiome Subset
18- to 65-year-old female subjects randomly assigned in the skin microbiome subset
Interventions
All subjects will take one self-portrait image of their face and hair
Subjects randomly assigned in the skin microbiome subset will complete the skin microbiome collection
All subjects will complete the lifestyle questionnaire
Eligibility Criteria
The target population is 18- to 65-year-old, healthy female subjects.
You may qualify if:
- Self-reported Monk skin type 1 to 10, targeting to complete at least 100 subjects for each Monk skin type.
- to 65 years old, targeting to complete:
- to 40-year-old age range: at least 50 subjects within each Monk type
- to 65-year-old age range: at least 50 subjects within each Monk type
- Lives within an Inner City, Urban, Suburban, or Rural community type (as determined by self-report or provided zip code), targeting to complete:
- Inner City/Urban community type: at least 25 subjects within each age range and Monk type
- Suburban/Rural community type: at least 25 subjects within each age range and Monk type
- Has electronically accepted the Consent for Photograph Release and ICD including Health Insurance Portability and Accountability Act (HIPAA) disclosure.
- Has a personal smartphone with a camera and an internet connection (wi-fi, cellular services, etc.).
- Intends to complete the study and willing and able to follow all study instructions.
You may not qualify if:
- Has known allergies or adverse reactions to topical adhesives.
- Is simultaneously participating in any other clinical study for the duration of this study or has participated in any product-use study within 30 days prior to remote Visit 1.
- Is an employee/contractor or immediate family member of the PI, study technology provider, laboratory, or Sponsor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laina Enterprises, Inc.
Apopka, Florida, 32712, United States
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2025
First Posted
September 25, 2025
Study Start
May 13, 2025
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
December 19, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share